Financial Lp Hrt Acquires 843,622 Shares of Aditxt (NASDAQ:ADTX) Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt bought 843,622 shares of the stock in a transaction on Thursday, June 4th. The stock was purchased at an average cost of $0.08 per share, with a total value of $67,489.76. Following the purchase, the insider directly owned 505,302 shares of the company’s stock, valued at approximately $40,424.16. This represents a -249.36% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt acquired 2,700 shares of Aditxt stock. The shares were bought at an average price of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total value of $3,588.30.

Aditxt Price Performance

Shares of ADTX traded down $0.01 during midday trading on Monday, hitting $0.05. The stock had a trading volume of 34,601,770 shares, compared to its average volume of 2,810,720. The firm has a market cap of $40,718.40, a price-to-earnings ratio of 0.00 and a beta of 0.84. The company has a 50 day simple moving average of $7.80 and a two-hundred day simple moving average of $170.33. Aditxt, Inc. has a twelve month low of $0.05 and a twelve month high of $53,451.08.

Aditxt (NASDAQ:ADTX) last released its quarterly earnings data on Tuesday, March 31st. The company reported $315,563.31 EPS for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research note on Monday, April 20th. Wall Street Zen raised Aditxt to a “sell” rating in a research note on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Aditxt has an average rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.